Menu

  • Home
  • About
    • Our Team
      • Board of Directors
        • Mr. Frank Holler, Chairman of the Board
        • Dr. Bruce McManus, CEO
        • Dr. Robert Sindelar
        • Dr. Donald Brooks
        • Mr. Bruce Milley
        • Dr. Volker Pfahlert
        • Mr. Richard Rees
        • Dr. George Schreiner
      • Management Team
        • Dr. Bruce McManus, CEO
        • Dr. Raymond Ng, Chief Informatics Officer
        • Dr. Scott Tebbutt, Chief Scientific Officer
        • Dr. Karen Lam, Chief Business Officer
        • Dr. Zsuzsanna Hollander, Chief Data Officer
        • Ms. Jo Lynn Mervyn, Finance Manager
      • Operations Team
        • Ms. Sara Assadian, Director, Clinical Research
        • Ms. Virginia Chen, Senior Data Scientist
        • Mr. Casey Shannon, Computational Biologist
        • Ms. Janet Wilson-McManus, Special Advisor
        • Ms. Paula Piper, Executive Administrator & Communications Officer
        • Dr. Robert Balshaw, Special Advisor – Statistical Lead
        • Paloma Stanar, Clinical Research Coordinator
      • Trainees
        • Dr. Amrit Singh, Postdoctoral Fellow
        • Dr. Ji-Young Kim, Assay Development Scientist
        • Daniel He, Graduate Student
    • Our Community of Partners
  • Our Programs
    • Biomarker Programs
    • Platforms
  • Our Services
  • News Room
    • News
    • Events
    • Media Coverage
    • Media Releases
      • PROOF Centre Collaboration Focuses on Prognostic Biomarkers for Chronic Kidney Disease
      • PROOF Centre to Begin Clinical Validation of Heart Transplant Rejection Liquid Biopsy Test Using the HTG EdgeSeq System, a Next-Generation Sequencing (NGS)-Based Platform
      • Mapping BC’s Path to Personalized Medicine
      • PROOF Centre & IO Informatics to Present at Partnering for Cures Conference
      • Centres of Excellence Align to Advance Novel Therapeutics and Diagnostics
      • PROOF Centre and MRM Proteomics Collaborate with the Jain Foundation to Identify Blood-Based Biomarkers of LGMD2B/Miyoshi Muscular Dystrophy
      • The PROOF Centre of Excellence Partners with HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test
      • PROOF Centre of Excellence and MRM Proteomics Partner to Bring New Tests to Clinic
      • New Blood Tests to put Clinical Trials for Allergic Asthma on the Fast Track
      • New Web-based App to Help Clinicians Improve Patient Care
      • The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program
      • Time to breathe a sigh of relief
      • PROOF Centre and Adiga Life Sciences launch biomarker discovery collaboration
  • Patient Resources
    • Biomarker Learning Centre
      • Organ Failure: We’re facing an epidemic.
      • What is a Cohort?
      • Biomarkers and Disease
      • Moving Towards Personalized Medicine
      • The ‘-Omics’ Approach
      • The Importance of Biobanking
      • What are Biomarkers?
  • Publications
  • Contact Us
PROOF Centre

March 10-12, 2011

Heart + Lung Health FEST 2011.

Sheraton Wall Centre, Vancouver, BC.

signals February 22, 2011 Events
  • ← Making excellent care for acute heart failure patients a priority through clinical innovation and research
  • March 12, 2011 →

What we do

The PROOF (Prevention of Organ Failure) Centre is a not-for-profit organization that develops blood tests to better predict, diagnose, manage and treat disease, by harnessing the power of clinical, molecular and computational science.

Fact Sheets

  • About the PROOF Centre
  • Heart Failure Program
  • COPD Program
  • CKD Program
  • Computational Services

Read about us

  • PROOF in the News

Partner with us

  • Our Community of Partners
Copyright © 2018 PROOF Centre